Related changes

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 21:10, 18 May 2024

List of abbreviations:

N: This edit created a new page (also see list of new pages)
m: This is a minor edit
b: This edit was performed by a bot
(±123): The page size changed by this number of bytes

17 May 2024

18:50

Small cell lung cancer‎ diffhist +1,494‎ Jwarner talk contribs →‎Temozolomide monotherapy {{#subobject:693cf4|Regimen=1}}

m 18:28

Follicular lymphoma‎ diffhist +636‎ Jwarner talk contribs

			m 16:21		Breast cancer‎‎ 2 changes history -12‎ [Jwarner‎ (2×)]
			m		16:21 (cur \| prev) +5‎ Jwarner talk contribs
			m		16:15 (cur \| prev) -17‎ Jwarner talk contribs

m 12:41

Colorectal cancer‎ diffhist +1,635‎ Jwarner talk contribs →‎CapeOx & Bevacizumab {{#subobject:62d39f|Regimen=1}}

16 May 2024

			12:41		Non-small cell lung cancer, nonsquamous‎‎ 9 changes history +13,593‎ [Jwarner‎ (9×)]
			m		12:41 (cur \| prev) -200‎ Jwarner talk contribs →‎Perioperative therapy
					12:40 (cur \| prev) +2,637‎ Jwarner talk contribs →‎Carboplatin, Pemetrexed, Durvalumab {{#subobject:cicjbr\|Regimen=1}}
					12:39 (cur \| prev) +2,546‎ Jwarner talk contribs →‎Carboplatin, Pemetrexed, Durvalumab {{#subobject:cicjbr\|Regimen=1}}
					12:38 (cur \| prev) +2,550‎ Jwarner talk contribs →‎Cisplatin, Pemetrexed, Durvalumab {{#subobject:cij8er\|Regimen=1}}
			m		12:34 (cur \| prev) +2‎ Jwarner talk contribs
			m		12:33 (cur \| prev) -78‎ Jwarner talk contribs →‎Advanced or metastatic disease, first-line
			m		12:32 (cur \| prev) +2‎ Jwarner talk contribs
			m		12:26 (cur \| prev) +1,150‎ Jwarner talk contribs →‎Cisplatin & Pemetrexed {{#subobject:uuhz8q\|Regimen=1}}
					12:25 (cur \| prev) +4,984‎ Jwarner talk contribs →‎Carboplatin & Pemetrexed {{#subobject:ijr18q\|Regimen=1}}

m 10:55

Non-small cell lung cancer‎ diffhist -80‎ Jwarner talk contribs →‎References

			m 00:39		Follicular lymphoma‎‎ 11 changes history -23,293‎ [Jwarner‎ (11×)]
			m		00:39 (cur \| prev) -6,881‎ Jwarner talk contribs →‎Consolidation after subsequent lines of therapy
			m		00:37 (cur \| prev) +105‎ Jwarner talk contribs →‎Relapsed or refractory, randomized data
			m		00:36 (cur \| prev) -1,395‎ Jwarner talk contribs →‎Maintenance after first-line therapy
			m		00:34 (cur \| prev) -12,670‎ Jwarner talk contribs →‎Consolidation after first-line therapy
			m		00:31 (cur \| prev) +35‎ Jwarner talk contribs →‎Advanced disease, first-line therapy, non-randomized or retrospective data
			m		00:31 (cur \| prev) +4,108‎ Jwarner talk contribs →‎Rituximab and hyaluronidase monotherapy {{#subobject:hfn369\|Regimen=1}}
			m		00:31 (cur \| prev) -3,990‎ Jwarner talk contribs →‎Advanced disease, first-line therapy, randomized data
			m		00:29 (cur \| prev) +105‎ Jwarner talk contribs →‎Early disease, definitive therapy
			m		00:26 (cur \| prev) -2,859‎ Jwarner talk contribs →‎Early disease, adjuvant therapy
			m		00:25 (cur \| prev) +29‎ Jwarner talk contribs
			m		00:24 (cur \| prev) +120‎ Jwarner talk contribs

15 May 2024

m 11:35

Follicular lymphoma‎ diffhist -7‎ Warner-admin talk contribs Text replacement - "*<big>We have moved How I Treat articles to a dedicated page.</big>" to "*''We have moved How I Treat articles to a dedicated page.''"

m 00:17

Esophageal cancer‎ diffhist +506‎ Jwarner talk contribs

14 May 2024

m 01:08

Small cell lung cancer‎ diffhist +975‎ Jwarner talk contribs

m 00:22

Carcinoma of unknown primary‎ diffhist +493‎ Jwarner talk contribs

13 May 2024

m 00:02

Breast cancer‎ diffhist +552‎ Jwarner talk contribs

12 May 2024

			m 02:27		Follicular lymphoma‎‎ 5 changes history +2,544‎ [Jwarner‎ (5×)]
			m		02:27 (cur \| prev) +900‎ Jwarner talk contribs
			m		02:14 (cur \| prev) 0‎ Jwarner talk contribs →‎Obinutuzumab monotherapy {{#subobject:942df7\|Regimen=1}}
			m		02:13 (cur \| prev) +195‎ Jwarner talk contribs
			m		02:10 (cur \| prev) +15,217‎ Jwarner talk contribs →‎Consolidation after subsequent lines of therapy
			m		02:09 (cur \| prev) -13,768‎ Jwarner talk contribs

			m 01:55		Breast cancer‎‎ 2 changes history +317‎ [Jwarner‎ (2×)]
			m		01:55 (cur \| prev) +180‎ Jwarner talk contribs →‎Regimen variant #2, 30 mg/m2 weekly {{#subobject:1b6c25\|Variant=1}}
			m		01:54 (cur \| prev) +137‎ Jwarner talk contribs →‎Regimen variant #2, 50 mg/m2 {{#subobject:f033fb\|Variant=1}}

m 01:46

Anaplastic glioma‎ diffhist +268‎ Jwarner talk contribs

Namespace:	Invert selection Associated namespace
Tag filter:
Page name:	Show changes to pages linked to the given page instead

			12:41		Non-small cell lung cancer, nonsquamous‎‎ 9 changes history +13,593‎ [Jwarner‎ (9×)]
			m		12:41 (cur \| prev) -200‎ Jwarner talk contribs →‎Perioperative therapy
					12:40 (cur \| prev) +2,637‎ Jwarner talk contribs →‎Carboplatin, Pemetrexed, Durvalumab {{#subobject:cicjbr\|Regimen=1}}
					12:39 (cur \| prev) +2,546‎ Jwarner talk contribs →‎Carboplatin, Pemetrexed, Durvalumab {{#subobject:cicjbr\|Regimen=1}}
					12:38 (cur \| prev) +2,550‎ Jwarner talk contribs →‎Cisplatin, Pemetrexed, Durvalumab {{#subobject:cij8er\|Regimen=1}}
			m		12:34 (cur \| prev) +2‎ Jwarner talk contribs
			m		12:33 (cur \| prev) -78‎ Jwarner talk contribs →‎Advanced or metastatic disease, first-line
			m		12:32 (cur \| prev) +2‎ Jwarner talk contribs
			m		12:26 (cur \| prev) +1,150‎ Jwarner talk contribs →‎Cisplatin & Pemetrexed {{#subobject:uuhz8q\|Regimen=1}}
					12:25 (cur \| prev) +4,984‎ Jwarner talk contribs →‎Carboplatin & Pemetrexed {{#subobject:ijr18q\|Regimen=1}}

			m 00:39		Follicular lymphoma‎‎ 11 changes history -23,293‎ [Jwarner‎ (11×)]
			m		00:39 (cur \| prev) -6,881‎ Jwarner talk contribs →‎Consolidation after subsequent lines of therapy
			m		00:37 (cur \| prev) +105‎ Jwarner talk contribs →‎Relapsed or refractory, randomized data
			m		00:36 (cur \| prev) -1,395‎ Jwarner talk contribs →‎Maintenance after first-line therapy
			m		00:34 (cur \| prev) -12,670‎ Jwarner talk contribs →‎Consolidation after first-line therapy
			m		00:31 (cur \| prev) +35‎ Jwarner talk contribs →‎Advanced disease, first-line therapy, non-randomized or retrospective data
			m		00:31 (cur \| prev) +4,108‎ Jwarner talk contribs →‎Rituximab and hyaluronidase monotherapy {{#subobject:hfn369\|Regimen=1}}
			m		00:31 (cur \| prev) -3,990‎ Jwarner talk contribs →‎Advanced disease, first-line therapy, randomized data
			m		00:29 (cur \| prev) +105‎ Jwarner talk contribs →‎Early disease, definitive therapy
			m		00:26 (cur \| prev) -2,859‎ Jwarner talk contribs →‎Early disease, adjuvant therapy
			m		00:25 (cur \| prev) +29‎ Jwarner talk contribs
			m		00:24 (cur \| prev) +120‎ Jwarner talk contribs

			m 02:27		Follicular lymphoma‎‎ 5 changes history +2,544‎ [Jwarner‎ (5×)]
			m		02:27 (cur \| prev) +900‎ Jwarner talk contribs
			m		02:14 (cur \| prev) 0‎ Jwarner talk contribs →‎Obinutuzumab monotherapy {{#subobject:942df7\|Regimen=1}}
			m		02:13 (cur \| prev) +195‎ Jwarner talk contribs
			m		02:10 (cur \| prev) +15,217‎ Jwarner talk contribs →‎Consolidation after subsequent lines of therapy
			m		02:09 (cur \| prev) -13,768‎ Jwarner talk contribs